DAPAGLIFLOZINA PROPANODIOL + CLORIDRATO DE SAXAGLIPTINA

Product Overview

About DAPAGLIFLOZINA PROPANODIOL + CLORIDRATO DE SAXAGLIPTINA

DAPAGLIFLOZINA PROPANODIOL + CLORIDRATO DE SAXAGLIPTINA is a prescription medicine formulated as a combination therapy for the management of blood glucose levels. This medication is indicated for use in adults diagnosed with type 2 diabetes mellitus to help improve glycemic control. It is intended to be used as an adjunct to diet and exercise. By combining two distinct pharmacological agents, this product provides a dual-action approach to managing hyperglycemia. Patients should always follow the specific administration instructions provided by their healthcare professional to ensure the medication is used safely and effectively. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

Key Benefits & Uses

• Assists in the regulation of blood sugar levels in adults with type 2 diabetes.
• Combines two active ingredients to target multiple pathways of glucose management.
• Supports long-term glycemic control when combined with appropriate lifestyle modifications.

Active Ingredient & Action

This medicine contains dapagliflozin propanediol and saxagliptin hydrochloride. Dapagliflozin acts as a sodium-glucose cotransporter 2 inhibitor, which reduces the reabsorption of glucose in the kidneys and promotes its excretion through urine. Saxagliptin is a dipeptidyl peptidase-4 inhibitor that increases the levels of incretin hormones, which help the body produce more insulin when needed and reduce the amount of glucose produced by the liver.

Important Notes

This medication must be prescribed by a qualified physician. Patients should inform their doctor about any existing kidney, liver, or heart conditions before starting treatment. Regular monitoring of blood glucose levels and kidney function is essential while taking this combination therapy. If you experience symptoms of an allergic reaction or severe side effects, seek medical attention immediately.